Kriengsak Lirdprapamongkol

Author

Also Known As

K Lirdprapamongkol, K. Lirdprapamongkol, KRIENGSAK LIRDPRAPAMONGKOL, Kriengsak Lirdprapamongkol, Lirdprapamongkol, Kriengsak

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Chulabhorn Research Institute Mahidol University Chulabhorn Graduate Institute Ministry of Education Srinakharinwirot University

About

Kriengsak Lirdprapamongkol is an author at Chulabhorn Research Institute specializing in medicine, pharmacology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	22	1K
2	Engineering	9	9	480
3	Biochemistry	4	4	170
4	Health Sciences	3	3	152
5	Natural Sciences	2	2	58

Kriengsak Lirdprapamongkol

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Vanillin suppresses in vitro invasion and in vivo metastasis of mouse breast cancer cells Kriengsak Lirdprapamongkol, Hiroaki Sakurai, Noritaka Kawasaki, European Journal of Pharmaceutical Sciences Vivo MetastasisBreast OncologyMedicineCell-matrix InteractionBreast Cancer	2005	181
Vanillin Suppresses Metastatic Potential of Human Cancer Cells through PI3K Inhibition and Decreases Angiogenesis in Vivo Kriengsak Lirdprapamongkol, Jan‐Peter Kramb, Tuangporn Suthiphongchai, Journal of Agricultural and Food Chemistry Decreases AngiogenesisCancer BiologyTumor BiologyOncologyVanillin Structure	2009	155
Mucoadhesive curcumin nanospheres: Biological activity, adhesion to stomach mucosa and release of curcumin into the circulation Natthakitta Suwannateep, Wijit Banlunara, Supason Wanichwecharungruang, Journal of Controlled Release Biological ActivityNanomedicineNanotherapeuticsEngineeringNanomaterials	2011	143
Electrospinning of alginate/soy protein isolated nanofibers and their release characteristics for biomedical applications Ratchada Wongkanya, Piyachat Chuysinuan, Chalinan Pengsuk, Journal of Science Advanced Materials and Devices	2017	117
Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles Chuda Chittasupho, Kriengsak Lirdprapamongkol, Prartana Kewsuwan, European Journal of Pharmaceutics and Biopharmaceutics NanomedicineCxcr4 AntagonistDrug TargetingEngineeringPolymer-drug Conjugate	2014	95
Studies of the in vitro cytotoxic, antioxidant, lipase inhibitory and antimicrobial activities of selected Thai medicinal plants Chutima Kaewpiboon, Kriengsak Lirdprapamongkol, Chantragan Srisomsap, BMC Complementary and Alternative Medicine	2012	92
Curcumin suppresses vasculogenic mimicry capacity of hepatocellular carcinoma cells through STAT3 and PI3K/AKT inhibition. Khajeelak Chiablaem, Kriengsak Lirdprapamongkol, Siriporn Keeratichamroen, PubMed	2014	91
Chrysin overcomes TRAIL resistance of cancer cells through Mcl-1 downregulation by inhibiting STAT3 phosphorylation Kriengsak Lirdprapamongkol, Hiroaki Sakurai, Sherif Abdelhamed, International Journal of Oncology Environmental SignalingChemoprevention StrategyApoptosisTrail ResistanceCell Death	2013	72
Proteomic analysis of cholangiocarcinoma cell line Chantragan Srisomsap, Phannee Sawangareetrakul, Pantipa Subhasitanont, PROTEOMICS	2004	67
Development and characterization of bio-derived polyhydroxyalkanoate nanoparticles as a delivery system for hydrophobic photodynamic therapy agents Sasivimon Pramual, Apinya Assavanig, Magnus Bergkvist, Journal of Materials Science Materials in Medicine NanomedicineEngineeringTherapeutic NanomaterialsPhotodynamic TherapyDrug Delivery Systems	2015	65

Page 1